Arkolith/Insider Trading/PHGE/Form 4/A

Solomon Jonathan Eitan

Chief Executive Officer, DirectorBiomX Inc. (PHGE) · full profile →Form 4/A · filed Apr 21, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 14, 2025Grant(A)127K—$0127K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 14, 2025Grant(A)381K—$0381K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-25-033485) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML